Phase II study of axitinib in patients with progressive, recurrent/metastatic adenoid cystic carcinoma

被引：5
|
作者：
Ho, Alan Loh
Sherman, Eric Jeffrey
Fury, Matthew G.
Baxi, Shrujal S.
Haque, Sofia
Sima, Camelia S.
Antonescu, Cristina R.
Katabi, Nora
Pfister, David G.
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 15期
关键词：
D O I：
10.1200/jco.2014.32.15_suppl.6093
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6093
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Phase II Study of Lenvatinib in Patients With Progressive, Recurrent or Metastatic Adenoid Cystic Carcinoma
    Tchekmedyian, Vatche
    Sherman, Eric J.
    Dunn, Lara
    Tran, Crystal
    Baxi, Shrujal
    Katabi, Nora
    Antonescu, Cristina R.
    Ostrovnaya, Irina
    Haque, Sofia S.
    Pfister, David G.
    Ho, Alan L.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (18) : 1529 - 1537
  • [2] Phase II Clinical Trial of Axitinib and Avelumab in Patients With Recurrent/Metastatic Adenoid Cystic Carcinoma
    Ferrarotto, Renata
    Sousa, Luana G.
    Feng, Lei
    Mott, Frank
    Blumenschein, George
    Altan, Mehmet
    Bell, Diana
    Bonini, Flavia
    Li, Kaiyi
    Marques-Piubelli, Mario L.
    Dal Lago, Eduardo A.
    Johnson, Jason J.
    Mitani, Yoshitsugu
    Godoy, Myrna
    Lee, Anna
    Kupferman, Michael
    Hanna, Ehab
    Glisson, Bonnie S.
    Elamin, Yasir
    El-Naggar, Adel
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (15) : 2843 - +
  • [3] A phase II study of lenvatinib in patients with progressive, recurrent/metastatic adenoid cystic carcinoma.
    Tchekmedyian, Vatche
    Sherman, Eric Jeffrey
    Dunn, Lara
    Tran, Crystal
    Katabi, Nora
    Ni, Ai
    Haque, Sofia
    Pfister, David G.
    Ho, Alan Loh
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [4] Phase II study of regorafenib in progressive, recurrent/metastatic adenoid cystic carcinoma.
    Ho, Alan Loh
    Sherman, Eric Jeffrey
    Baxi, Shrujal S.
    Haque, Sofia
    Ni, Ai
    Antonescu, Cristina R.
    Katabi, Nora
    Morris, Luc G.
    Chan, Timothy An-thy
    Pfister, David G.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [5] A Phase II Study of Dovitinib in Patients with Recurrent or Metastatic Adenoid Cystic Carcinoma
    Dillon, Patrick M.
    Petroni, Gina R.
    Horton, Bethany J.
    Moskaluk, Christopher A.
    Fracasso, Paula M.
    Douvas, Michael G.
    Varhegyi, Nikole
    Zaja-Milatovic, Snjezana
    Thomas, Christopher Y.
    CLINICAL CANCER RESEARCH, 2017, 23 (15) : 4138 - 4145
  • [6] A phase II study of lenvatinib plus pembrolizumab in patients with progressive, recurrent/metastatic adenoid cystic carcinoma.
    Mohamadpour, Maliheh
    Sherman, Eric Jeffrey
    Kriplani, Anuja
    Fetten, James Vincent
    Dunn, Lara
    Michel, Loren S.
    Hung, Kin Wai
    Baxi, Shrujal S.
    McDonald, Erin
    Conybeare, Rachel
    Katabi, Nora
    Ostrovnaya, Irina
    Pfister, David G.
    Ho, Alan Loh
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [7] Randomized Phase II Study of Axitinib versus Observation in Patients with Recurred or Metastatic Adenoid Cystic Carcinoma
    Kang, Eun Joo
    Ahn, Myung-Ju
    Ock, Chan-Young
    Lee, Keun-Wook
    Kwon, Jung Hye
    Yang, Yaewon
    Choi, Yoon Hee
    Kim, Min Kyoung
    Ji, Jun Ho
    Yun, Tak
    Nam, Byung-Ho
    Kim, Sung-Bae
    Keam, Bhumsuk
    CLINICAL CANCER RESEARCH, 2021, 27 (19) : 5272 - 5279
  • [8] A phase II study of dovitinib in patients with recurrent or metastatic adenoid cystic carcinoma (ACC).
    Dillon, Patrick Michael
    Petroni, Gina R.
    Moskaluk, Chris
    Fracasso, Paula M.
    Douvas, Michael G.
    Perez, Jose Ricardo
    Varhegyi, Nikole
    Zaja-Milatovic, Snjezana
    Thomas, Christopher Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [9] Phase II study of sunitinib in patients (pts) with progressive metastatic adenoid cystic carcinoma (ACC)
    Hotte, S. J.
    Chen, E. X.
    Hirte, H. W.
    Moretto, P.
    Turner, S.
    Chin, S. F.
    Wang, L.
    MacAlpine, K.
    Siu, L. L.
    EJC SUPPLEMENTS, 2008, 6 (12): : 65 - 65
  • [10] Randomized phase II study of axitinib versus observation in patients with recurred or metastatic adenoid cystic carcinoma.
    Keam, Bhumsuk
    Kang, Eun Joo
    Ahn, Myung-Ju
    Ock, Chan-Young
    Lee, Keun Wook
    Kwon, Jung Hye
    Yang, Yaewon
    Choi, Yoon Hee
    Kim, Min Kyoung
    Ji, Jun Ho
    Yun, Tak
    Nam, Byung-Ho
    Kim, Sung-Bae
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
12345